The device has been usesd in more than 15,000 cases globally, according to a news release. It features a wide range of implants for interbody fusion.
Implanet’s CEO, Ludovic Lastennet, said SqualeTM is expected to launch in the U.S. by summer.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
